By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ActivBiotics 

128 Spring Street

Lexington  Massachusetts  02421  U.S.A.
Phone: 781-372-4800 Fax: 781-274-9129


SEARCH JOBS


Industry
Pharmaceutical






Company News
ActivBiotics Assignee Issues First Distribution of Cash to Creditors 6/20/2008 11:05:19 AM
ActivBiotics' Intellectual Property Assets, Including Drug Product Candidates, Sold for $3.5 Million 4/3/2008 7:45:05 AM
ActivBiotics' Intellectual Property Assets, Including Drug Product Candidates, Sold for $3.5 Million 4/2/2008 2:34:31 PM
ActivBiotics Receives FDA Orphan Drug Designation for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis of Cancer 3/6/2008 7:03:49 AM
ActivBiotics Set to Sell Proprietary Assets, Including Drug Product Candidates, on March 14, 2008 3/5/2008 7:44:35 AM
ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics 2/25/2008 8:13:36 AM
ActivBiotics Outlines a Clinical Path Forward to Examine if Rifalazil Is Superior to Azithromycin in the Treatment of Chlamydia STD 2/19/2008 6:58:33 AM
ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication 2/5/2008 7:30:12 AM
ActivBiotics Completes Sale of Fixed Assets 1/29/2008 7:07:39 AM
ActivBiotics Completes Sale of Fixed Assets; Expands Due Diligence Candidates 1/28/2008 2:58:47 PM
1234
//-->